Evidence-Based Recommendations on the Use of Immunotherapies and Monoclonal Antibodies in the Treatment of Male Reproductive Cancers
Current Oncology · 14.02.2025 · 32 (2) · 108
DOI: 10.3390/curroncol32020108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 14.02.2025. Verfasst von Farhan Khalid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ 07740, USA. Hauptthemen laut MEDLINE: Immunotherapy, Antibodies, Monoclonal, Genital Neoplasms, Male. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The incidence of male reproductive cancers, including prostate, testicular, and penile cancers, has risen in recent years, raising important health concerns. Prostate cancer is the second leading cause of cancer-related mortality in men, while penile cancer, though rare, typically affects men over 60. Testicular cancer, with a lifetime risk of about 0.4% in men, is most common among adolescents and young adults, decreasing sharply after the age of 40. Traditional treatments include chemotherapy, radiation, surgery, and combinations thereof, but advancements in immunotherapy and monoclonal antibodies are showing promising results, particularly for genitourinary cancers. These therapies, targeting immune checkpoints and tumor-specific antigens, are gaining traction as effective alternatives for resistant cases. This review provides evidence-based recommendations on current and emerging immunotherapy and monoclonal antibody treatments for male reproductive cancers, highlighting future directions to optimize patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ 07740, USA.
- Department of Internal medicine, Graduate Medical Education, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
- Department of Medicine, Al-Aleem Medical College, Lahore 54000, Pakistan.
ORCID-Profile: Zubair Hassan Bodla, Karan Yagnik
Zitieren
APA
Khalid, F., Bodla, Z. H., Gaddameedi, S. R., Macasaet, R., Yagnik, K., Niaz, Z., Fish, P. N., Du, D., & Shah, S. (2025). Evidence-Based Recommendations on the Use of Immunotherapies and Monoclonal Antibodies in the Treatment of Male Reproductive Cancers. Current Oncology, 32(2), 108. https://doi.org/10.3390/curroncol32020108
Vancouver
Khalid F, Bodla ZH, Gaddameedi SR, Macasaet R, Yagnik K, Niaz Z, et al. Evidence-Based Recommendations on the Use of Immunotherapies and Monoclonal Antibodies in the Treatment of Male Reproductive Cancers. Current Oncology. 2025;32(2):108. doi:10.3390/curroncol32020108
BibTeX
@article{Khalid2025,
author = {Khalid, Farhan and Bodla, Zubair Hassan and Gaddameedi, Sai Rakshith and Macasaet, Raymart and Yagnik, Karan and Niaz, Zahra and Fish, Peter N and Du, Doantrang and Shah, Shazia},
title = {Evidence-Based Recommendations on the Use of Immunotherapies and Monoclonal Antibodies in the Treatment of Male Reproductive Cancers},
journal = {Current Oncology},
year = {2025},
volume = {32},
number = {2},
pages = {108},
doi = {10.3390/curroncol32020108}
}
EUVIMED